Skip to main content
Fig. 3 | BMC Neurology

Fig. 3

From: Early risk assessment of circulating endothelial progenitor cells and plasma stromal cell-derived factor-1 for nondisabling ischemic cerebrovascular events

Fig. 3

Peripheral blood was isolated and cultured for 48 h in EPCs. A colony assay (Fig. 3a, magnification × 200) and MTT assay (Fig. 3b) were used to detect the proliferation ability of each group. The Transwell assay was used to test the cell migration ability (Fig. 3c, magnification × 100); and the counting chart is shown in Fig. 3d. The cell migration ability of the HR-NICE group was weakened (P < 0.01). The cell migration ability of the NHR-NICE group was weaker than that of the NC group, and the difference was significant (P < 0.05). *P < 0.01, **P < 0.05

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us